Haley Howell

Haley Howell has a diverse work experience in the biotechnology and pharmaceutical industries. Haley started their career as an Office Assistant at Suffolk University from 2008 to 2010. In 2010, they joined Constellation Pharmaceuticals as a Clinical and Finance Associate until 2015.

From 2015 to 2017, Haley worked at Shire as a Clinical Project Manager and later as a Senior Clinical Project Manager. Haley then moved on to Epizyme, where they held the positions of Senior Clinical Project Manager from 2017 to 2018, and Associate Director of Clinical Operations from 2018 to 2019.

In 2019, Haley joined Magenta Therapeutics as an Associate Director of Clinical Operations until 2020, and later became the Director of Clinical Operations from 2020 to 2021. Currently, they are working at Disc Medicine as the Director of Clinical Operations since 2021 and has recently been promoted to the position of Senior Director of Clinical Development Operations starting in January 2023.

Haley Howell received their Bachelor of Science in Business Administration (BSBA), with cum laude honors, from Suffolk University, where they specialized in Global Business and Management. Following their undergraduate studies, in 2013 to 2014, they pursued a Certificate Program in Clinical Trials Management and Regulatory Compliance at the University of Chicago's Graham School. There is no specific information available regarding their education at the University of Hartford.